Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Mar 13;106(6):1089-94.
doi: 10.1038/bjc.2012.65. Epub 2012 Feb 28.

Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia

R Agarwal  1 , V Harding, D Short, R A Fisher, N J Sebire, R Harvey, D Patel, P M Savage, A K P Lim, M J Seckl
Affiliations

Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia

R Agarwal et al. Br J Cancer. .

Abstract

Background: Neo-angiogenesis is a hallmark of cancer. The aim of this study was to test the hypothesis, in a prospective patient cohort, that in low-risk gestational trophoblastic neoplasia (LR-GTN) the uterine artery pulsatility index (UAPI), a measure of tumour vascularity, can predict resistance to methotrexate chemotherapy (MTX-R).

Methods: 286 LR-GTN patients (Charing Cross Hospital (CXH) score 0-8, or FIGO score 0-6) were treated with methotrexate between January 2008 and June 2011 at CXH. During staging investigations, patients underwent a Doppler ultrasound to assess the UAPI.

Results: 239 patients were assessable for both UAPI and MTX-R. The median UAPI was lower (higher vascularity) in MTX-R compared with MTX-sensitive patients (0.8 vs 1.4, P<0.0001). In multivariate logistic regression, UAPI≤1 predicted MTX-R, independent of both CXH and FIGO scores. The risk of MTX-R in patients with a FIGO score of 6 and UAPI≤1 was 100% vs 20% in patients with UAPI>1 (χ(2) P<0.0001).

Conclusion: UAPI represents an independently validated clinically useful predictor of MTX-R in LR-GTN. Further, consideration of whether to incorporate UAPI into the FIGO scoring system is now warranted so that patients with a score of 6 and a UAPI ≤1 might be upstaged and offered combination chemotherapy rather than MTX.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Box-plots of FIGO score (A) and UAPI (B) by resistance to MTX-R. *Mann–Whitney U test, Resistant=YES (n=113), Sensitive=NO (n=126).
See this image and copyright information in PMC

References

    1. Agarwal R, Strickland S, McNeish IA, Patel DC, Foskett M, Boultbee JE, Newlands ES, Seckl MJ (2002) Doppler ultrasonography of the uterine artery and the response to chemotherapy in patients with gestational trophoblastic tumors. Clin Cancer Res 8: 1142–1147 - PubMed
    1. Aghajanian C (2011) Treatment of low-risk gestational trophoblastic neoplasia. J Clin Oncol 29: 786–788 - PubMed
    1. Bagshawe KD (1976) Risk and prognostic factors in trophoblastic neoplasia. Cancer 38: 1373–1385 - PubMed
    1. Berndt S, Perrier d’Hauterive S, Blacher S, Pequeux C, Lorquet S, Munaut C, Applanat M, Herve MA, Lamande N, Corvol P, van den Brule F, Frankenne F, Poutanen M, Huhtaniemi I, Geenen V, Noel A, Foidart JM (2006) Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium. FASEB J 20: 2630–2632 - PubMed
    1. Bower M, Newlands ES, Holden L, Short D, Brock C, Rustin GJ, Begent RH, Bagshawe KD (1997) EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J Clin Oncol 15: 2636–2643 - PubMed

Publication types

Substances